Tracheitis Diagnosed With 68Ga-PSMA PET/CT in a Patient With COVID-19
- 27 May 2022
- journal article
- editorial
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (10) , e656-e657
Abstract
A 57-year-old man with newly diagnosed with prostate cancer was admitted to our department for 68Ga–prostate-specific membrane antigen PET/CT imaging. The patient, who was asymptomatic at the time of imaging, had increased diffuse 68Ga–prostate-specific membrane antigen uptake in the trachea on PET/CT. No ground-glass density suggestive of pneumonia in both lungs was observed. The patient, whose symptoms developed 2 days after PET/CT imaging, was diagnosed with coronavirus disease 2019 by real-time polymerase chain reaction.Keywords
This publication has 8 references indexed in Scilit:
- Incidental finding of COVID-19 infection after [68Ga]Ga-PSMA-11 PET/CT imaging in a patient with prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series2021
- New wine in old bottles: 68Ga-PSMA-11 PET/CT reveals COVID-19 in patients with prostate cancer2021
- 68Ga-PSMA PET/CT With Incidental Finding of COVID-19 in an Asymptomatic PatientClinical Nuclear Medicine, 2020
- Avid 68Ga-PSMA Uptake in Periappendicular AbscessClinical Nuclear Medicine, 2020
- Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancerTumori Journal, 2020
- [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review2020
- Pitfalls in Gallium-68 PSMA PET/CT Interpretation—A Pictorial ReviewTomography, 2018